[1]Reubi J C, Laissue J A. Multiple action of somatostatin in neoplastic disease[J]. Trends in Pharmacological Sciences, 1995, 16: 110-115.
[2]Lucignani G, Bombardieri E. Progress and challenges in neuroendocrine and neural crest tumours:molecular imaging and therapy[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36: 2081-2088.
[3]Reubi J C, Schar J C, Waser B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2000, 27(3): 273-282.
[4]Forrer F, Uusijarvi H, Waldherr C, et al. A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31(9): 1257-1262.
[5]Buchmann I, Henze M, Engelbrecht S, et al. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC(Octreoscan) SPECT in patients with neuroendocrine tumours[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34(10): 1617-1626.
[6]Krenning E P, Kwekkeboom D J, Bakker W H, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe-1] and[123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients[J]. European Journal of Nuclear Medicine and Molecular Imaging, 1993, 20(8): 716-731.
[7]Velikyan I , Xu H , Nair M , et al. Robust labeling and comparative preclinical characterization of DOTATOC and DOTATATE[J]. Nuclear Medicine and Biology, 2012, 39(5): 628-639.
[8]Blower P J, Lewis J S, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine[J]. Nuclear Medicine and Biology, 1996, 23 (8): 957-980.
[9]Hanaoka H, Tominaga H, Yamada K, et al. Evaluation of 64Cu-labeled DOTA-D-Phe-1-Tyr3-octreotide (64Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors[J]. Annals of Nuclear Medicine, 2009, 23(6): 559-567.
[10]Malmberg C, Ripa R S , Johnbeck C B, et al. 64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors: head-to-head comparison with 68Ga-DOTATOC in 60 patients[J]. Journal of Nuclear Medicine, 2015, 56(12): 1895-1900.
[11]陈玉清,梁积新,李光,等. 阴离子交换法从辐照后的Ni靶中分离64Cu[J]. 同位素,2012,25(3):144-148.Chen Yuqing, Liang Jixin, Li Guang, et al. Chemical separation of 64Cu from irradiated Ni target by anion exchange method[J]. Journal of Isotope, 2012, 25(3): 144-148(in Chinese). |